Free Trial

This company has been marked as potentially delisted and may not be actively trading.

NASDAQ:CNTG

Centogene (CNTG) Stock Price, News & Analysis

Centogene logo

About Centogene Stock (NASDAQ:CNTG)

Advanced Chart

Key Stats

Today's Range
N/A
50-Day Range
$0.07
$0.35
52-Week Range
N/A
Volume
8.36 million shs
Average Volume
150,868 shs
Market Capitalization
$8.80 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
N/A
Consensus Rating
N/A

Company Overview

Receive CNTG Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Centogene and its competitors with MarketBeat's FREE daily newsletter.

CNTG Stock News Headlines

Gold buying hits 4-year high
The perfect gold play right now? (currently under $10) Everything in the news now lines up perfectly for an epic bull rally in gold. JP Morgan and Goldman Sachs have a price target of $4,000. My research tells me gold could surpass $5,000 in the coming months. Folks using a very specific gold strategy since the 80s could have made more than 60 TIMES their money. Today, you can take advantage of a similar setup for around $10
CNTGF Centogene N.V.
Centogene N.V. (CNTG)
See More Headlines

CNTG Stock Analysis - Frequently Asked Questions

Centogene (NASDAQ:CNTG) announced its earnings results on Wednesday, November, 24th. The company reported ($1.08) earnings per share for the quarter, missing the consensus estimate of ($0.59) by $0.49. The company had revenue of $35.60 million for the quarter, compared to analysts' expectations of $31.91 million.

Centogene (CNTG) raised $60 million in an IPO on Thursday, November 7th 2019. The company issued 4,000,000 shares at a price of $14.00-$16.00 per share. SVB Leerink and Evercore ISI acted as the underwriters for the IPO and Baird and BTIG were co-managers.

Based on aggregate information from My MarketBeat watchlists, some other companies that Centogene investors own include Avino Silver & Gold Mines (ASM), Lincoln National (LNC), Advanced Micro Devices (AMD), Applied Genetic Technologies (AGTC), Catalyst Pharmaceuticals (CPRX), Fulcrum Therapeutics (FULC) and VBI Vaccines (VBIV).

Company Calendar

Last Earnings
11/24/2021
Today
7/06/2025
Fiscal Year End
12/31/2025

Industry, Sector and Symbol

Stock Exchange
NASDAQ
Sector
Medical
Industry
Medical laboratories
Sub-Industry
Healthcare
Current Symbol
NASDAQ:CNTG
Fax
N/A
Employees
810
Year Founded
N/A

Profitability

Trailing P/E Ratio
N/A
Forward P/E Ratio
N/A
P/E Growth
N/A
Pretax Margin
N/A

Debt

Sales & Book Value

Annual Sales
$48.54 million
Price / Cash Flow
N/A
Book Value
($1.01) per share
Price / Book
N/A

Miscellaneous

Free Float
N/A
Market Cap
$8.80 million
Optionable
Not Optionable
Beta
-0.67
5G Stocks: The Path Forward is Profitable Cover

Enter your email address and we'll send you MarketBeat's guide to investing in 5G and which 5G stocks show the most promise.

Get This Free Report

This page (NASDAQ:CNTG) was last updated on 7/6/2025 by MarketBeat.com Staff
From Our Partners